27 Oct 2009 by CLC Bio
CLC bio has begun an expansion phase of the distribution of its Next Generation Sequencing solutions into the Japanese market.
To handle direct relations with its Japanese customers, CLC bio has accepted Filgen as its new reseller and appointed David Leangen as chief executive officer of CLC bio Japan.
Carl Zeiss has introduced an integrated solution to acquire and analyse multi-scale and multi-modal…
The Honeycomb system from Logicall, a division of Whitehorse Scientific, is an affordable, easy to …
The first part of the EquipNet toolkit series is designed to educate and inform on best practice fo…
